Skip to main content
Top

International Journal of Hematology

Issue Special Issue 2/2002

Content (65 Articles)

Hematomorphology

Plasmacytic lesions of the bone marrow

Bong Hak Hyun

Stem Cell Transplantation

Mini-transplantation strategy for solid tumors

Yoichi Takaue

Update on Hypercoagulability

Targeted gene disruption of natural anticoagulant proteins in mice

Tetsuhito Kojima

Update on Hypercoagulability

Treatment of venous thromboembolism

Walter Ageno

Update on Hypercoagulability

Recent advances in the diagnosis of antiphospholipid syndrome

Hyun-Sook Chi

Recent Advances in Apheresis

Granulocyte transfusion in the G-CSF era

Thomas H. Price

Recent Advances in Apheresis

The eight-year experience of plasmapheresis in patients with neurological diseases

Hou-Chang Chiu, Jiann-Horng Yeh, Wei-Hung Chen

Thalassemia and Hemoglobinopathy

Thalassemia and abnormal hemoglobin

Suthat Fucharoen, Pranee Winichagoon

Thalassemia and Hemoglobinopathy

Thalassemia mutations and their clinical aspects in Japan

Yukio Hattori

Thalassemia and Hemoglobinopathy

β-Thalassemia in the Korean population

Sung Sup Park, Han-Ik Cho

Thalassemia and Hemoglobinopathy

Carrier screening and genetic counselling in β-thalassemia

Antonio Cao

Malignant Lymphoma

PTCL: Lessons from adult T-cell leukemia

Masao Matsuoka

Malignant Lymphoma

NK cell lymphoma

Kazuo Oshimi

Update on Bleeding Disorders

Idiopathic thrombocytopenic purpura: Pathophysiology and management

Yeon S. Ahn, Lawrence L Horstman

Update on Bleeding Disorders

Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura

Han-Mou Tsai

Update on Bleeding Disorders

Management of bleeding disorders by prohemostatic therapy

Marcel M. Levi, Roel Vink, Evert de Jonge

Update on Bleeding Disorders

Molecular diagosis of von Willebrand disease

Changgeng Ruan

Histocompatibility in Field of Hematology

Current and emerging technology for HLA typing

Derek Middleton

Histocompatibility in Field of Hematology

Minor histocompatibility antigens-targets of graft versus leukemia responses

Stanley R. Riddell, M. Murata, S. Bryant, E. H. Warren

Understanding and Treatment of Acquired Aplastic Anemia

Views on the pathophysiology of aplastic anaemia

Edward C. Gordon-Smith, J. C. Marsh, F. M. Gibson

Understanding and Treatment of Acquired Aplastic Anemia

New advances in the treatment of acquired severe aplastic anaemia

Jill Hows

Understanding and Treatment of Acquired Aplastic Anemia

The relationship of aplastic anemia and PNH

Neal S. Young, Jaroslaw P. Maciejewski, Elaine Sloand, Guiben Chen, Weihua Zeng, Antonio Risitano, Akira Miyazato

Understanding and Treatment of Acquired Aplastic Anemia

Aplastic anemia in the orient

Seiji Kojima

The Biology and Treatment of Acute Myeloid Leukemia

Clinical importance of genetic findings in adult AML

Clara D. Bloomfield

The Biology and Treatment of Acute Myeloid Leukemia

Biologically risk directed therapy for improved trial development and outcomes in patients with AML

Robert J. Arceci

The Biology and Treatment of Acute Myeloid Leukemia

New advances in the treatment of acute promyelocytic leukemia

Dan Douer

Myelodysplastic Syndrome

Molecular pathogenesis of MDS

Hisamaru Hirai

Myelodysplastic Syndrome

Important features of myelodysplastic syndrome

Wolf-K. Hofmann, H. Phillip Koeffler

Myelodysplastic Syndrome

The Myelodysplastic Syndromes: Morphology, risk assessment, and clinical management (2002)

John M. Bennett, Peter A. Kouides, Stephen J. Forman

Safety Issues in Blood & Blood Products Transfusion

Human T lymphotropic virus type-I and adult T-cell leukemia in Japan

Kazunari Yamaguchi, Toshiki Watanabe

Safety Issues in Blood & Blood Products Transfusion

Human herpesvirus 6 and human herpesvirus 7: Emerging pathogens in transplant patients

Duncan A. Clark

Safety Issues in Blood & Blood Products Transfusion

The quest for quality blood banking program in the new millennium the American way

Dae Un Kim

Non-malignant Hematologic Disorders in Childhood

Childhood ITP

Haewon C. Kim

Non-malignant Hematologic Disorders in Childhood

An approach to the diagnosis and treatment of bleeding disorders in infants

Thomas C. Abshire

Non-malignant Hematologic Disorders in Childhood

Non-myeloablative hematopoietic cell transplant for treatment of nonmalignant disorders in children

Ann E. Woolfrey, Michael A. Pulsipher, Rainer Storb

Treatment of Childhood Malignancy

Current concepts in treatment of childhood acute lymphoblastic leukemia

Ching-Hon Pui

Treatment of Childhood Malignancy

Designer drugs: New directed therapies for cancer

Stephen A. Feig

Treatment of Childhood Malignancy

Umbilical cord blood for unrelated bone marrow replacement; Asia Bank and Japan cord blood bank network update

Hideo Mugishima, Tuneo Takahashi, Tokiko Nagamura, Sigetaka Asano, Hidehiko Saito

Role of Blood and Marrow Nurses in Field of Transplants

Role of the Advanced Practice Nurse in blood and marrow transplantation

Joyce L. Neumann

Role of Blood and Marrow Nurses in Field of Transplants

The present state of advanced practice nursing in hematopoietic stem cell transplantation field in Korea

Jung Hee Hong

Current Concepts of the Myeloproliferative Diseases

Treatment of polycythemia vera with recombinant interferon

Richard T. Silver

Current Concepts of the Myeloproliferative Diseases

The therapy of myelofibrosis: Targeting pathogenesis

Ruben A. Mesa

Current Concepts of the Myeloproliferative Diseases

Basic sciences of the myeloproliferative diseases: Pathogenic mechanisms of ET and PV

Rosemary E. Gale

Current Concepts of the Myeloproliferative Diseases

What is the standard treatment in essential thrombocythemia

Tiziano Barbui

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine